Vasopressors and Inotropes in the Treatment of Human Septic Shock: Effect on Innate Immunity?
Open Access
- 24 February 2011
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 35 (1) , 206-213
Abstract
Catecholamines have been suggested to modulate innate immune responses in experimental settings. The significance hereof in the treatment of human septic shock is unknown. We therefore sought if and how vasopressor/inotropic doses relate to pro-inflammatory mediators during treatment of septic shock. We prospectively studied 20 consecutive septic shock patients. For 3 days after admission, hemodynamic variables, lactate and plasma levels of interleukins (IL)-6 and 8, tumor necrosis factor (TNF)-α, and elastase-α1-antitrypsin were measured six hourly. Doses of vasoactive drugs were recorded. Of the 20 patients, nine died in the intensive care unit. Dobutamine doses were positively associated and related to TNF-α plasma levels, independently of disease severity, hemodynamics, and outcome, in multivariable models. Dopamine doses were positively associated with IL-6, and norepinephrine was inversely associated with IL-8 and TNF-α levels. Our observations suggest that catecholamines used in the treatment of human septic shock differ in their potential modulation of the innate immune response to sepsis in vivo. Dobutamine treatment may contribute to circulating TNF-α and dopamine to IL-6, independently of activated neutrophils. Conversely, norepinephrine may lack pro-inflammatory actions.Keywords
This publication has 31 references indexed in Scilit:
- Comparison of Dopamine and Norepinephrine in the Treatment of ShockNew England Journal of Medicine, 2010
- Pivotal Role of the α2A-Adrenoceptor in Producing Inflammation and Organ Injury in a Rat Model of SepsisPLOS ONE, 2009
- Upregulation of Phagocyte-Derived Catecholamines Augments the Acute Inflammatory ResponsePLOS ONE, 2009
- Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study)*Critical Care Medicine, 2009
- Catecholamines induce an inflammatory response in human hepatocytesCritical Care Medicine, 2008
- Cytokine profiles as markers of disease severity in sepsis: a multiplex analysisCritical Care, 2007
- Catecholamines, parasympathetic stimuli, or cortisol for overwhelming sepsis?*Critical Care Medicine, 2006
- Dobutamine does not influence inflammatory pathways during human endotoxemia*Critical Care Medicine, 2006
- Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study*Critical Care Medicine, 2006
- α-Atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shockCritical Care Medicine, 2001